Review Articles

TP53 aberrations in chronic lymphocytic leukemia: an overview of the clinical implications of improved diagnostics

Hospital Clinic of Barcelona, University of Barcelona, Institute of Biomedical Research August Pi i Sunyer (IDIBAPS), Barcelona, and CIBERONC, Spain
Hôpital Avicenne, AP-HP, UMR INSERMU978/Paris 13 University, Bobigny, France
Università Vita-Salute San Raffaele and IRCCS Ospedale San Raffaele, Milan, Italy
Medical University of Vienna, Austria
Center of Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic
Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
University of Oxford, UK
Internal Medicine III, Ulm University, Germany and Innere Medizin I, Universitätsklinikum des Saarlandes, Homburg, Germany
Vol. 103 No. 12 (2018): December, 2018 https://doi.org/10.3324/haematol.2018.187583